Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.a7f5d217.1771891698.c2547da2
Business
Read More
Thousands of Flights Are Canceled as Storm Slams Northeast Airports
Airlines suspended operations at some major airports and expect to restart some flights on Monday and more on Tuesday.
After Saks Bankruptcy, Richard Baker Says He Saved Luxury Department Stores
Richard Baker wanted to create a retail empire when he combined Saks Fifth Avenue and Neiman Marcus. About a year later, it filed for bankruptcy.
IBM is the latest AI casualty. Shares are tanking 11% on Anthropic programming language threat
International Business Machines Corp. (IBM) signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Monday, Dec. 8, 2025. Michael Nagle | Bloomberg | Getty Images International Business Machines stock is getting slammed, becoming the latest victim of rapidly developing AI technology, after Anthropic’s Claude announced COBOL capabilities. Shares…
Are You Leveraging the Diverse Talent on Your Board?
Tapping into a range of views prevents the groupthink and blind spots that undermine decision-making and creativity.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.5ca5c117.1771862310.f44413a8
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.5ca5c117.1771858609.f31ba7c1
What’s Happened Since the Supreme Court’s Tariff Ruling
After the Trump administration’s punishing tariffs were invalidated, the president said he would impose new tariffs using a different authority. It’s been a whirlwind.
U.K., Australia and Others Worse Off Under Trump’s New Tariffs
Many important U.S. trading partners are facing higher duties after President Trump, reacting to a Supreme Court setback, set the rate on a new set of global tariffs at 15 percent.
Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly
Novo Nordisk stock fell 13% Monday after it said its next-generation weight loss drug didn’t meet its key goal of showing that it wasn’t inferior to Eli Lilly’s rival drug. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly’s rival drug tirzepatide after 84 weeks,…